• Power to treat
  • Before-and-after treatment photos
  • Inflammatory/noninflammatory lesion reduction
• Power to please
• Patient support
• For patients

Indication and Important Safety Information: Acanya Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. Do not prescribe if the patient has shown hypersensitivity to clindamycin, benzoyl peroxide, or to lincomycin. Acanya Gel is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Discontinuation is recommended if significant diarrhea, bloody diarrhea, severe abdominal cramping, or colitis (including pseudomembranous colitis) develops. Clindamycin taken orally or through IV may result in severe colitis, which may result in death. Anaphylaxis, as well as other allergic reactions leading to hospitalizations, has been reported in postmarketing use of products containing clindamycin/benzoyl peroxide. If a patient develops symptoms of an allergic reaction such as swelling and shortness of breath, they should be instructed to discontinue use and contact a physician immediately. Patients should be advised to avoid contact with the eyes or mucous membranes and to minimize sun exposure following the application of Acanya Gel. In controlled clinical trials, the following application-site adverse reactions occurred in less than 0.2% of patients treated with Acanya Gel: application-site pain (0.1%), application-site exfoliation (0.1%), and application site irritation (0.1%).